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Introduction
Bacterial asparaginase obtained from Escherichia coli and
Erwinia chrysanthemi are used as medicine to treat acute
lymphocytic leukemia and non-Hodgkin lymphoma.
Despite the therapeutic properties of such enzymes there
have been reports on adverse reactions, eventually so
severe as to impede some patients of using the medicine.
Besides, the only drug Brazil used to import is no longer
produced. Considering these two factors our proposition
is to produce non-bacterial asparaginase.
Objective
Purify and characterize asparaginase II from Saccharo-
myces cerevisiae cloned and expressed in Pichia pastoris
aiming to produce an antileukemic drug.
Methodology
The established methodology to purify the recombinant
asparaginase involved three steps: ultrafiltration using a 50
kDa Amicon membrane, molecular exclusion chromato-
graphy in Superdex200 and anion exchange chromatogra-
phy in Mono-Q column. Homogeneity was confirmed by
SDS-PAGE in reducing conditions and by MALDI-TOF/
TOF mass spectrometry; enzyme activity was determined
by the hydroxylaminolysis reaction. Isoelectric point was
estimated by two-dimensional electrophoresis using the
image analysis software ImageMaster (GE Healthcare);
molecular mass was determined using 12% SDS-PAGE
and molecular exclusion chromatography. The recombi-
nant asparaginase glycidic portion in its homogeneous
form was analyzed by SDS-PAGE in reducing conditions
followed by periodic acid/Schiff stain. An enzymatic clea-
vage of N-linked oligosaccharides was performed with
PNGase F at 37ºC for 3 hours and subsequent analysis by
SDS-PAGE. Enzyme optimum temperature and pH were
also characterized.
Results
The homogeneous fraction obtained from the anionic
exchange chromatography showed a specific activity of
204 IU mg-1 which represents a purification level of 10.9
and an enzyme activity recovery of 51.3% as compared to
the crude extract. After electrophoresis in reducing and
denaturing conditions two bands were observed with a
estimated molecular mass of 48 and 46 kDa. It was verified
that these two bands correspond to asparaginase II from S.
cerevisae and that both are glycosylated. The native
enzyme molecular mass was estimated to be 136 kDa
suggesting that the enzyme is an oligomer. Two optimum
pH values (7.2 and 9.0) were observed. Optimum tempera-
ture at both pH, 7.2 and 9.0, was 46ºC nevertheless the
activity at 37ºC was 92% of that at 46°C. After enzyme
deglycosilation both bands migrated as a single one in
SDS-PAGE, indicating that the main difference between
them is the glycosylation level. Isoelectric point was esti-
mated at approximately 4.55.
Conclusion
These results support further research aiming at the use of
the recombinant yeast asparaginase as an antileukemic
medicine. The pre-clinic in vitro studies have already been
initiated.
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